Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
179 studies found for:    Open Studies | "Skin Diseases, Infectious"
Show Display Options
Rank Status Study
21 Recruiting Severe Cutaneous Adverse Reactions in Thailand
Conditions: Steven-Johnson Syndrome;   Toxic Epidermal Necrolysis;   Drug Reaction With Eosinophilia and Systemic Symptoms;   Acute Generalized Exanthematous Pustulosis;   Generalized Bullous Fixed Drug Eruption
22 Not yet recruiting Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess
Condition: Furunculosis
Intervention: Biological: Antimicrobial TheraGauze
23 Not yet recruiting Topical Clobetasol for the Treatment of Toxic Epidermal Necrolysis
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Clobetasol 0.05% ointment
24 Unknown  The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
Condition: Impetigo
Interventions: Drug: papaya 1% extract ointment;   Drug: mupirocin 2% ointment
25 Unknown  Citriodiol® and Impetigo
Condition: Impetigo
Intervention: Drug: p-menthane-3,8-diol oil
26 Recruiting Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study
Condition: Onychomycosis
Interventions: Drug: NVXT topical;   Drug: Placebo (Vehicle) Topical
27 Not yet recruiting Safety of Either a Single or Two IV Doses of Orbactiv in Subjects With ABSSSI
Condition: Skin Diseases, Bacterial
Interventions: Drug: oritavancin;   Drug: placebo (D5W)
28 Not yet recruiting Penicillin for the Emergency Department Outpatient Treatment of CELLulitis
Conditions: Cellulitis;   Wound Infection;   Abscess
Interventions: Drug: Flucloxacillin;   Drug: Phenoxymethylpenicillin;   Drug: Placebo (for phenoxymethylpenicillin)
29 Not yet recruiting Radiolabelled IV and Oral Metabolism Study of F901318
Condition: Invasive Aspergillosis
Interventions: Drug: IV F901318;   Drug: Oral F901318
30 Recruiting Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
Condition: Hidradenitis Suppurativa
Intervention: Drug: Adalimumab
31 Recruiting Group Psychotherapy for Patients With Hidradenitis Suppurativa: Effects in Quality of Life
Condition: Hidradenitis
Intervention: Behavioral: psychotherapy
32 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness
Condition: Hidradenitis Suppurativa (HS)
33 Not yet recruiting A Study of a New Leishmania Vaccine Candidate ChAd63-KH
Condition: Leishmaniasis, Cutaneous
Intervention: Drug: ChAd63-KH
34 Recruiting Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis
Condition: Foot Infection Tinea Pedis
Interventions: Drug: infected group;   Drug: control group
35 Not yet recruiting Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes
Condition: Herpes Labialis
Interventions: Drug: Pritelivir 5% w/w ointment;   Drug: Pritelivir ointment matching placebo;   Drug: Zovirax® cream
36 Recruiting Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot
Condition: Tinea Pedis
Interventions: Drug: Nitric Oxide;   Drug: Water
37 Recruiting Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: Ciclopirox 80 mg/g
38 Not yet recruiting Hospitalization at Home: The Acute Care Home Hospital Program for Adults
Conditions: Pneumonia;   Heart Failure;   Cellulitis;   Urinary Tract Infections
Interventions: Other: Home hospitalization;   Other: Inpatient Hospitalization
39 Recruiting SB208 for the Treatment of Tinea Pedis
Condition: Tinea Pedis
Interventions: Drug: SB208 2%;   Drug: SB208 4%;   Drug: SB208 16%;   Drug: Vehicle Gel
40 Recruiting A Multi-centre, Double-blind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)
Condition: Distal Subungual Onychomycosis
Interventions: Drug: MOB015B;   Drug: MOB015B Vehicle

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years